A detailed history of Engineers Gate Manager LP transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 17,360 shares of HRMY stock, worth $693,532. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,360
Previous 15,619 11.15%
Holding current value
$693,532
Previous $524,000 0.19%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$28.81 - $33.01 $50,158 - $57,470
1,741 Added 11.15%
17,360 $523,000
Q1 2024

May 15, 2024

SELL
$29.93 - $35.06 $885,838 - $1.04 Million
-29,597 Reduced 65.46%
15,619 $524,000
Q4 2023

Feb 14, 2024

BUY
$19.2 - $33.78 $868,147 - $1.53 Million
45,216 New
45,216 $1.46 Million
Q4 2022

Feb 14, 2023

BUY
$45.4 - $60.91 $314,304 - $421,679
6,923 Added 56.33%
19,212 $1.06 Million
Q3 2022

Nov 14, 2022

BUY
$42.06 - $55.45 $516,875 - $681,425
12,289 New
12,289 $544,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.36B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.